A Prospective Study about Safety and Efficacy of Perioperative Lidocaine Infusion

Authors

  • Vakhtang Shoshiashvili Department of Anesthesiology and Intensive Care, TSMU First University Clinic,Tbilisi, Faculty of medicine, European University, Tbilisi, Georgia.
  • Ashraf El-Molla Department of Anesthesia, Misr University for Science and Technology, Cairo, Egypt.
  • Fawzia Aboul Fetouh Department of Anesthesia, Misr University for Science and Technology, Cairo, Egypt.
  • Rashed Alotaibi Prince Sultan Military Medical City, Riyadh, Kingdom of Saudi Arabia.
  • Abir Kandil Prince Sultan Military Medical City, Riyadh, Kingdom of Saudi Arabia.
  • Osama Shaalan Prince Sultan Military Medical City, Riyadh, Kingdom of Saudi Arabia.
  • Yasser Ali Ministry of Health, Egypt.

DOI:

https://doi.org/10.9734/bpi/nhmmr/v8/3723E

Keywords:

Lidocaine, perioperative infusion, opioid, balanced anesthesia, multimodal analgesia

Abstract

Respiratory depression, immunosuppression, muscle rigidity, negative inotropism, nausea, vomiting, hyperalgesia, urine retention, postoperative ileus, and drowsiness are all clinically significant adverse effects of opioids. Perioperative opioids are a significant contributor to the opioid epidemic in the united states and other nations. As a result, non-opioid analgesics, particularly lidocaine, are becoming more popular for perioperative use.

A total of 185 adult patients were divided into two groups: control group i (105 patients) [fentanyl group] and group ii (80 patients) [opioid free anesthesia group]. Patients of both groups received at anesthetic induction: lidocaine 1.5 mg/kg bolus followed by 1.5 mg/kg/h infusion intraoperatively, and 1.5-2 mg/kg/h infusion for 2-8 hours postoperatively. Both groups received other analgesic adjuvants such as diclofenac 75 mg, paracetamol 1 gm, and mgso4 30-50 mg/kg intraoperatively. A supplemental fentanyl 1 mcg/kg was used if there is increase of mean arterial pressure (map) and/ or heart rate (hr) more than 20% above baseline. Analgesic requirements were documented following intraoperative fentanyl consumption and a visual analog scale (vas) pain score evaluation at the time of immediate recovery and after 24 hours postoperatively.

Supplemental intraoperative fentanyl was needed in 8.6% of cases in group i, and in 30% of cases in group ii. Group ii also needed a higher minimum alveolar concentration (mac) of sevoflurane during first 30 minutes. Both groups needed analgesia immediately post extubation if surgeries were less than 3 hours. After 8 hours of lidocaine infusion, there was no need for additional opioids for 24 hours and only paracetamol 1 g and/or diclofenac 75 mg were enough in both groups. No significant differences in bowel function were observed between the 2 groups.

Safety and efficacy of perioperative lidocaine infusion have been demonstrated. With minimal non-opioid analgesia for 24 hours, a post-operative lidocaine infusion for 5-8 hours was sufficient to ease discomfort. Opioid use during induction gives more hemodynamic stability and it is reasonable to use it in combination with lidocaine.

Published

2022-04-22

How to Cite

Vakhtang Shoshiashvili, Ashraf El-Molla, Fawzia Aboul Fetouh, Rashed Alotaibi, Abir Kandil, Osama Shaalan, & Yasser Ali. (2022). A Prospective Study about Safety and Efficacy of Perioperative Lidocaine Infusion. New Horizons in Medicine and Medical Research Vol. 8, 100–107. https://doi.org/10.9734/bpi/nhmmr/v8/3723E